Lindbrook Capital, LLC - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4,575
+50.2%
3,0500.0%0.00%
Q4 2022$3,046
-39.1%
3,0500.0%0.00%
-100.0%
Q3 2022$5,000
-44.4%
3,0500.0%0.00%0.0%
Q2 2022$9,000
+12.5%
3,0500.0%0.00%0.0%
Q1 2022$8,000
-42.9%
3,0500.0%0.00%
-50.0%
Q4 2021$14,0003,0500.00%
Other shareholders

There were no reported owners of TCR2 THERAPEUTICS INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of TCR2 THERAPEUTICS INC shareholders